115 related articles for article (PubMed ID: 25078313)
1. Synthesis and biological evaluation of andrographolide analogues as anti-cancer agents.
Preet R; Chakraborty B; Siddharth S; Mohapatra P; Das D; Satapathy SR; Das S; Maiti NC; Maulik PR; Kundu CN; Chowdhury C
Eur J Med Chem; 2014 Oct; 85():95-106. PubMed ID: 25078313
[TBL] [Abstract][Full Text] [Related]
2. Andrographolide induces apoptosis in B16F-10 melanoma cells by inhibiting NF-κB-mediated bcl-2 activation and modulating p53-induced caspase-3 gene expression.
Pratheeshkumar P; Sheeja K; Kuttan G
Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):143-51. PubMed ID: 21682651
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, cytotoxicity, and structure-activity relationship (SAR) studies of andrographolide analogues as anti-cancer agent.
Das B; Chowdhury C; Kumar D; Sen R; Roy R; Das P; Chatterjee M
Bioorg Med Chem Lett; 2010 Dec; 20(23):6947-50. PubMed ID: 20974534
[TBL] [Abstract][Full Text] [Related]
4. Andrographolide induces cell cycle arrest at G2/M phase and cell death in HepG2 cells via alteration of reactive oxygen species.
Li J; Cheung HY; Zhang Z; Chan GK; Fong WF
Eur J Pharmacol; 2007 Jul; 568(1-3):31-44. PubMed ID: 17512926
[TBL] [Abstract][Full Text] [Related]
5. SRS06, a new semisynthetic andrographolide derivative with improved anticancer potency and selectivity, inhibits nuclear factor-κB nuclear binding in the A549 non-small cell lung cancer cell line.
Lim JC; Jeyaraj EJ; Sagineedu SR; Wong WS; Stanslas J
Pharmacology; 2015; 95(1-2):70-7. PubMed ID: 25613753
[TBL] [Abstract][Full Text] [Related]
6. NCI in vitro and in silico anticancer screen, cell cycle pertubation and apoptosis-inducing potential of new acylated, benzylidene and isopropylidene derivatives of andrographolide.
Wong CC; Sagineedu SR; Sumon SH; Sidik SM; Phillips R; Lajis NH; Stanslas J
Environ Toxicol Pharmacol; 2014 Sep; 38(2):489-501. PubMed ID: 25168151
[TBL] [Abstract][Full Text] [Related]
7. Semisynthesis and in vitro anticancer activities of andrographolide analogues.
Jada SR; Subur GS; Matthews C; Hamzah AS; Lajis NH; Saad MS; Stevens MF; Stanslas J
Phytochemistry; 2007 Mar; 68(6):904-12. PubMed ID: 17234223
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationships of andrographolide analogues as novel cytotoxic agents.
Nanduri S; Nyavanandi VK; Thunuguntla SS; Kasu S; Pallerla MK; Ram PS; Rajagopal S; Kumar RA; Ramanujam R; Babu JM; Vyas K; Devi AS; Reddy GO; Akella V
Bioorg Med Chem Lett; 2004 Sep; 14(18):4711-7. PubMed ID: 15324893
[TBL] [Abstract][Full Text] [Related]
9. Andrographolide inhibits multiple myeloma cells by inhibiting the TLR4/NF-κB signaling pathway.
Gao H; Wang J
Mol Med Rep; 2016 Feb; 13(2):1827-32. PubMed ID: 26707811
[TBL] [Abstract][Full Text] [Related]
10. 12-Amino-andrographolide analogues: synthesis and cytotoxic activity.
Kasemsuk S; Sirion U; Suksen K; Piyachaturawat P; Suksamrarn A; Saeeng R
Arch Pharm Res; 2013 Dec; 36(12):1454-64. PubMed ID: 23709127
[TBL] [Abstract][Full Text] [Related]
11. Benzylidene derivatives of andrographolide inhibit growth of breast and colon cancer cells in vitro by inducing G(1) arrest and apoptosis.
Jada SR; Matthews C; Saad MS; Hamzah AS; Lajis NH; Stevens MF; Stanslas J
Br J Pharmacol; 2008 Nov; 155(5):641-54. PubMed ID: 18806812
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro cytotoxicity of novel C-12 substituted-14-deoxy-andrographolide derivatives as potent anti-cancer agents.
Kandanur SG; Golakoti NR; Nanduri S
Bioorg Med Chem Lett; 2015 Dec; 25(24):5781-6. PubMed ID: 26561364
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vitro cytotoxicity of andrographolide-19-oic acid analogues as anti-cancer agents.
Chen D; Song Y; Lu Y; Xue X
Bioorg Med Chem Lett; 2013 Jun; 23(11):3166-9. PubMed ID: 23628335
[TBL] [Abstract][Full Text] [Related]
14. Rugulactone derivatives act as inhibitors of NF-κB activation and modulates the transcription of NF-κB dependent genes in MDA-MB-231cells.
Mohapatra DK; Reddy DS; Ramaiah MJ; Ghosh S; Pothula V; Lunavath S; Thomas S; Valli SN; Bhadra MP; Yadav JS
Bioorg Med Chem Lett; 2014 Mar; 24(5):1389-96. PubMed ID: 24508135
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anticancer activity of some novel indolo[3,2-b]andrographolide derivatives as apoptosis-inducing agents.
Song Y; Xin Z; Wan Y; Li J; Ye B; Xue X
Eur J Med Chem; 2015 Jan; 90():695-706. PubMed ID: 25506809
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of new C-12(α/β)-(N-) sulfamoyl-phenylamino-14-deoxy-andrographolide derivatives as potent anti-cancer agents.
Kandanur SGS; Nanduri S; Golakoti NR
Bioorg Med Chem Lett; 2017 Jul; 27(13):2854-2862. PubMed ID: 28527822
[TBL] [Abstract][Full Text] [Related]
17. New substituted C-19-andrographolide analogues with potent cytotoxic activities.
Sirion U; Kasemsook S; Suksen K; Piyachaturawat P; Suksamrarn A; Saeeng R
Bioorg Med Chem Lett; 2012 Jan; 22(1):49-52. PubMed ID: 22154665
[TBL] [Abstract][Full Text] [Related]
18. Andrographolide radiosensitizes human esophageal cancer cell line ECA109 to radiation in vitro.
Wang ZM; Kang YH; Yang X; Wang JF; Zhang Q; Yang BX; Zhao KL; Xu LP; Yang LP; Ma JX; Huang GH; Cai J; Sun XC
Dis Esophagus; 2016 Jan; 29(1):54-61. PubMed ID: 25059546
[TBL] [Abstract][Full Text] [Related]
19. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and cytotoxicity of novel 14α-
Mokenapelli S; Gutam M; Vadiyaala N; Yerrabelli JR; Banerjee S; Roy P; Kancha RK; Kunduru BR; Sagurthi SR; Chitneni PR
Nat Prod Res; 2021 Jan; 35(2):289-297. PubMed ID: 31219346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
